Stocks and Investing Stocks and Investing
Tue, January 3, 2023

Stephen Baxter Maintained (THC) at Buy with Increased Target to $59 on, Jan 3rd, 2023


Published on 2024-10-28 00:42:31 - WOPRAI, Stephen Baxter
  Print publication without navigation


Stephen Baxter of Wells Fargo, Maintained "Tenet Healthcare Corporation" (THC) at Buy with Increased Target from $48 to $59 on, Jan 3rd, 2023.

Stephen has made no other calls on THC in the last 4 months.



There are 8 other peers that have a rating on THC. Out of the 8 peers that are also analyzing THC, 1 agrees with Stephen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $45 on, Monday, October 24th, 2022


These are the ratings of the 7 analyists that currently disagree with Stephen


  • Ann Hynes of "Mizuho" Maintained at Strong Buy with Decreased Target to $60 on, Wednesday, November 2nd, 2022
  • Jamie Perse of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $80 on, Tuesday, November 1st, 2022
  • John Ransom of "Raymond James" Maintained at Strong Buy with Decreased Target to $80 on, Thursday, October 27th, 2022
  • Jason Cassorla of "Citigroup" Maintained at Strong Buy with Decreased Target to $76 on, Tuesday, October 25th, 2022
  • Whit Mayo of "SVB Leerink" Maintained at Buy with Decreased Target to $55 on, Tuesday, October 25th, 2022
  • Pito Chickering of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $48 on, Monday, October 24th, 2022
  • Sarah James of "Barclays" Maintained at Buy with Decreased Target to $67 on, Monday, October 24th, 2022
Contributing Sources